Neurodegenerative Diseases Overview

Neurodegenerative diseases are progressive, fatal disorders of the nervous system that represent a leading cause of disability and death worldwide. For you as a pre-medical student, mastering their distinct pathological hallmarks is not only foundational for clinical practice but is also a high-yield topic for the MCAT, where differentiating these conditions based on cellular and anatomic changes is essential. This overview will build from core concepts to advanced pathology, equipping you with the knowledge to diagnose conceptually and excel on exam questions.

Foundations of Neurodegeneration and Proteinopathy

At their core, neurodegenerative diseases are defined by the selective, premature death of specific neuronal populations. While clinical symptoms vary widely, a unifying theme is the abnormal accumulation of misfolded proteins in the brain, a process called proteinopathy. Think of these protein aggregates as molecular "garbage" that neurons cannot clear, leading to toxic gain-of-function, loss of normal protein activity, and eventual cell death. For the MCAT, you should focus on linking each disease to its specific pathological protein and the brain region most affected, as this is a common line of questioning. Understanding this protein-region axis provides a framework for recalling clinical features, such as why a disease targeting the hippocampus causes memory loss.

Alzheimer Disease: Pathology of Plaques and Tangles

Alzheimer disease is the most common cause of dementia, and its diagnosis is confirmed by characteristic post-mortem brain findings. The two signature lesions are amyloid beta plaques and neurofibrillary tangles. Amyloid beta plaques are extracellular deposits of a misfolded peptide fragment, while neurofibrillary tangles are intracellular aggregates of hyperphosphorylated tau protein, a microtubule-associated protein that becomes dysfunctional. Tau pathology correlates more closely with cognitive decline than amyloid plaques. On a macroscopic level, progressive cortical atrophy is evident, particularly in the temporal lobes and hippocampus, explaining the hallmark symptoms of memory impairment and disorientation. An MCAT strategy here is to remember the "A" in Alzheimer for "Amyloid" and "Atrophy," and to note that tau tangles spread in a predictable pattern from the entorhinal cortex.

Parkinson Disease and the Lewy Body

Parkinson disease is primarily a movement disorder resulting from the degeneration of dopaminergic neurons in the substantia nigra pars compacta of the midbrain. The pathognomonic histological finding is the Lewy body, an intraneuronal inclusion body whose primary structural component is aggregated alpha-synuclein protein. The loss of dopamine-producing neurons in this region leads to the classic triad of resting tremor, bradykinesia, and rigidity. For exam purposes, a common trap is confusing Lewy bodies with the inclusions of other diseases; always associate alpha-synuclein and the substantia nigra exclusively with Parkinson disease. Furthermore, Lewy bodies are also found in other synucleinopathies like dementia with Lewy bodies, but the nigral degeneration is central to Parkinson's motor symptoms.

Amyotrophic Lateral Sclerosis: Selective Motor Neuron Death

Amyotrophic lateral sclerosis is characterized by the progressive degeneration of both upper motor neurons in the motor cortex and lower motor neurons in the brainstem and spinal cord. This dual involvement leads to a combination of symptoms: upper motor neuron signs (e.g., spasticity, hyperreflexia) and lower motor neuron signs (e.g., muscle atrophy, fasciculations). A critical and testable distinction is the absence of sensory deficits; ALS is a pure motor system disease. The pathology involves inclusions of proteins like TDP-43 in most cases, but for the MCAT, emphasize the anatomic fact of combined upper and lower motor neuron loss. When presented with a patient vignette describing progressive weakness with both spasticity and atrophy but no numbness, ALS should be your leading diagnosis.

Other Essential Neurodegenerative Disorders

Several other neurodegenerative diseases with distinct pathologies are frequently tested. Frontotemporal dementia often presents with personality and language changes before memory loss; its pathological hallmark is the Pick body, an intracellular tau aggregate found in a variant called Pick's disease. Huntington disease is an autosomal dominant trinucleotide repeat disorder causing chorea and psychiatric symptoms, with striking caudate atrophy visible on neuroimaging due to selective degeneration of the striatum. Prion diseases, such as Creutzfeldt-Jakob disease, are rapidly progressive dementias caused by infectious misfolded prion proteins, leading to microscopic spongiform change—vacuoles that give the brain tissue a sponge-like appearance. For these rarer conditions, the MCAT often tests direct association: Pick bodies with FTD, caudate atrophy with Huntington, and spongiform change with prion disease.

Common Pitfalls

1. Confusing Inclusion Bodies: Students often mix up the protein compositions of different inclusion bodies. Remember: Alzheimer has tau tangles and amyloid plaques; Parkinson has alpha-synuclein Lewy bodies; and Frontotemporal dementia can have tau Pick bodies. A mnemonic: "Parkinson has Lewy bodies (think P-L), Alzheimer has Amyloid and Tau (think A-T)."

1. Misattributing Sensory Symptoms: A classic exam trap is to include ALS in a differential for a patient with sensory loss. ALS affects only motor neurons; the presence of sensory deficits (numbness, tingling) should immediately steer you toward other diagnoses like peripheral neuropathy or spinal cord lesions.

1. Overlooking Anatomic Correlates: Linking pathology to brain region is key. For instance, associating caudate atrophy specifically with Huntington disease, or substantia nigra degeneration with Parkinson, is more high-yield than merely recalling the protein involved. On the MCAT, questions often combine anatomy with pathology.

1. Equating All Dementia Pathologies: Not all dementia is Alzheimer disease. Frontotemporal dementia features frontal and temporal lobe atrophy with different behavioral presentations, while prion diseases have a much faster progression. Always match the clinical tempo and initial symptoms to the underlying pathology.

Summary

• Alzheimer disease is defined by amyloid beta plaques, neurofibrillary tangles of hyperphosphorylated tau, and cortical atrophy, leading to progressive memory loss.
• Parkinson disease stems from Lewy bodies composed of alpha-synuclein in the substantia nigra, causing tremor, bradykinesia, and rigidity.
• Amyotrophic lateral sclerosis involves degeneration of both upper and lower motor neurons with no sensory deficits, resulting in progressive weakness and spasticity.
• Frontotemporal dementia is associated with Pick bodies (tau inclusions), Huntington disease with characteristic caudate atrophy, and prion diseases with microscopic spongiform change.
• For the MCAT, focus on the inseparable link between the specific protein aggregate, the brain region affected, and the resulting clinical syndrome to differentiate these diseases efficiently.